PE Ratio Chart

View PE Ratio for BVNRY.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View PE Ratio Chart
Start Trial

Historical PE Ratio Data

View and export this data back to 2014. Start Trial.
Date Value
September 15, 2026 10.02
September 14, 2026 10.02
September 11, 2026 10.09
September 10, 2026 10.08
September 09, 2026 10.07
September 08, 2026 10.38
September 04, 2026 10.89
September 03, 2026 10.89
September 02, 2026 10.99
September 01, 2026 10.99
August 31, 2026 10.77
August 28, 2026 10.50
August 27, 2026 10.60
August 26, 2026 10.83
August 25, 2026 10.83
August 24, 2026 10.61
August 21, 2026 10.44
August 20, 2026 9.559
August 19, 2026 9.583
August 18, 2026 9.345
August 17, 2026 9.257
August 14, 2026 9.163
August 13, 2026 8.950
August 12, 2026 8.878
August 11, 2026 8.671
Date Value
August 10, 2026 8.671
August 07, 2026 8.729
August 06, 2026 8.815
August 05, 2026 8.815
August 04, 2026 8.815
August 03, 2026 8.827
July 31, 2026 8.757
July 30, 2026 8.690
July 29, 2026 8.642
July 28, 2026 8.642
July 27, 2026 8.463
July 24, 2026 8.412
July 23, 2026 8.556
July 22, 2026 8.836
July 21, 2026 8.836
July 20, 2026 8.887
July 17, 2026 8.983
July 16, 2026 9.108
July 15, 2026 8.959
July 14, 2026 8.911
July 13, 2026 8.777
July 10, 2026 8.930
July 09, 2026 9.037
July 08, 2026 9.142
July 07, 2026 9.362

PE Ratio Definition

The Price to Earnings Ratio (PE Ratio) is calculated by taking the stock price / EPS Diluted (TTM). This metric is considered a valuation metric that confirms whether the earnings of a company justifies the stock price. There isn't necesarily an optimum PE ratio, since different industries will have different ranges of PE Ratios. Because of this, PE Ratio is great to evaluate from a relative standpoint with other similar companies.

Read full definition.

PE Ratio Range, Past 5 Years

View PE Ratio Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

PE Ratio Benchmarks

View PE Ratio Benchmarks
Start Trial
Evaxion AS --
Genmab A/S 27.04
Ascendis Pharma A/S 18.27
Zealand Pharma A/S 7.168
Agenus, Inc. 2.701

PE Ratio Related Metrics